Cleared Traditional

K901337 - HILAL EMBOLIZATION MICROCOIL(TM)

K901337 is the FDA 510(k) clearance for HILAL EMBOLIZATION MICROCOIL(TM) by Cook, Inc.. It is a Class 2 Neurology device (product code HCG) cleared through the Traditional 510(k) pathway after a 236-day FDA review.

K901337 · Cook, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1990
Decision
236d
Days
Class 2
Risk

K901337 is an FDA 510(k) clearance for the HILAL EMBOLIZATION MICROCOIL(TM). Classified as Device, Neurovascular Embolization (product code HCG), Class II - Special Controls.

Submitted by Cook, Inc. (Bloomington, US). The FDA issued a Cleared decision on November 13, 1990 after a review of 236 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5950 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cook, Inc. devices

Submission Details

510(k) Number K901337 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 1990
Decision Date November 13, 1990
Days to Decision 236 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d slower than avg
Panel avg: 148d · This submission: 236d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HCG Device, Neurovascular Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5950
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCG Device, Neurovascular Embolization

All 116
Devices cleared under the same product code (HCG) and FDA review panel - the closest regulatory comparables to K901337.
TRUEFILL PVA PARTICLES
K951314 · Cordis Neurovascular, Inc. · Aug 1995
HELIX SHAPED COILS WITH DACRON FIBERS, MODIFIED
K911779 · Target Therapeutics · Nov 1991
HELIX SHAPED COILS WITH DACRON FIBERS, MODIFIED
K913312 · Target Therapeutics · Nov 1991
MODIFIED TARGET THERAPEUTICS COILS
K901721 · Target Therapeutics · Jul 1990
COIL AND COIL DELIVERY SYSTEM
K891688 · Target Therapeutics · Sep 1989